Search Results

There are 57354 results for: content related to: Digoxin Inhibits Blood Vessel Density and HIF-1a Expression in Castration-Resistant C4-2 Xenograft Prostate Tumors

  1. You have free access to this content
    A cohort study of digoxin exposure and mortality in men with prostate cancer

    BJU International

    Volume 113, Issue 2, February 2014, Pages: 236–245, Evelyn M. Flahavan, Linda Sharp, Kathleen Bennett and Thomas I. Barron

    Version of Record online : 13 AUG 2013, DOI: 10.1111/bju.12287

  2. Digitalis in the Elderly

    Journal of the American Geriatrics Society

    Volume 37, Issue 9, September 1989, Pages: 873–882, Arshag D. Mooradian, Vicki L. Grieff, Rubin Bressler, Richard L. Reed and Frank I. Marcus

    Version of Record online : 27 APR 2015, DOI: 10.1111/j.1532-5415.1989.tb02269.x

  3. You have free access to this content
    Ouabain–digoxin antagonism in rat arteries and neurones

    The Journal of Physiology

    Volume 592, Issue 5, 1 March 2014, Pages: 941–969, Hong Song, Eiji Karashima, John M. Hamlyn and Mordecai P. Blaustein

    Version of Record online : 3 FEB 2014, DOI: 10.1113/jphysiol.2013.266866

    Corrected by:

    CORRIGENDUM: Corrigendum

    Vol. 592, Issue 21, 4803, Version of Record online: 31 OCT 2014

  4. Challenges in Therapeutic Drug Monitoring of Digoxin Using Immunoassays

    Resolving Erroneous Reports in Toxicology and Therapeutic Drug Monitoring: A Comprehensive Guide

    Amitava Dasgupta, Pages: 237–263, 2012

    Published Online : 9 JUL 2012, DOI: 10.1002/9781118347867.ch12

  5. Suitability of digoxin as a P-glycoprotein probe: Implications of other transporters on sensitivity and specificity

    The Journal of Clinical Pharmacology

    Volume 54, Issue 1, January 2014, Pages: 3–13, Ahmed M. Nader and David R. Foster

    Version of Record online : 26 OCT 2013, DOI: 10.1002/jcph.200

  6. You have free access to this content
    Targeting Na+/K+-translocating adenosine triphosphatase in cancer treatment

    Clinical and Experimental Pharmacology and Physiology

    Volume 42, Issue 5, May 2015, Pages: 427–443, Cameron T. Durlacher, Kevin Chow, Xiao-Wu Chen, Zhi-Xu He, Xueji Zhang, Tianxin Yang and Shu-Feng Zhou

    Version of Record online : 23 APR 2015, DOI: 10.1111/1440-1681.12385

  7. You have free access to this content
    Application of permeability-limited physiologically-based pharmacokinetic models: Part II - prediction of p-glycoprotein mediated drug–drug interactions with digoxin

    Journal of Pharmaceutical Sciences

    Volume 102, Issue 9, September 2013, Pages: 3161–3173, Sibylle Neuhoff, Karen Rowland Yeo, Zoe Barter, Masoud Jamei, David B. Turner and Amin Rostami-Hodjegan

    Version of Record online : 19 MAY 2013, DOI: 10.1002/jps.23607

  8. In Vitro P-Glycoprotein Interactions and Steady-State Pharmacokinetic Interactions Between Tolvaptan and Digoxin in Healthy Subjects

    The Journal of Clinical Pharmacology

    Volume 51, Issue 5, May 2011, Pages: 761–769, Dr Susan E. Shoaf, Mr Yoshihiro Ohzone, Dr Shin-ichi Ninomiya, Dr Masayuki Furukawa, Dr Patricia Bricmont, Dr Eiji Kashiyama and Dr Suresh Mallikaarjun

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270010376193

  9. Evaluation of Pharmacokinetic Interactions Between Vildagliptin and Digoxin in Healthy Volunteers

    The Journal of Clinical Pharmacology

    Volume 47, Issue 8, August 2007, Pages: 998–1004, Yan-Ling He, Ron Sabo, Gangadhar Sunkara, Marie-Noëlle Bizot, Gilles-Jacques Riviere, Selene Leon, Monica Ligueros-Saylan, William P. Dole and Dan Howard

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270007301802

  10. Removal of digoxin by column for specific adsorption of β2-microglobulin: A potential use for digoxin intoxication

    Clinical Pharmacology & Therapeutics

    Volume 69, Issue 6, June 2001, Pages: 422–430, Shuichi Tsuruoka, Eiichi Osono, Kenta Nishiki, Atsuhiro Kawaguchi, Tatsuhiko Arai, Sigeo Furuyoshi, Tetsuo Saito, Satoru Takata, Koichi Sugimoto, Satoshi Kurihara and Akio Fujimura

    Version of Record online : 19 JUN 2001, DOI: 10.1067/mcp.2001.116061

  11. Digoxin pharmacokinetics: Role of renal failure in dosage regimen design

    Clinical Pharmacology & Therapeutics

    Volume 18, Issue 1, July 1975, Pages: 9–21, Jeffrey R. Koup, William J. Jusko, Charles M. Elwood and Romesh K. Kohli

    Version of Record online : 4 JAN 2016, DOI: 10.1002/cpt19751819

  12. A new interference in some digoxin assays: Anti-murine heterophilic antibodies

    Clinical Pharmacology & Therapeutics

    Volume 60, Issue 5, November 1996, Pages: 593–598, Cesar Liendo, Jalal K. Ghali and Steven W. Graves

    Version of Record online : 19 NOV 1996, DOI: 10.1016/S0009-9236(96)90157-5

  13. The Effect of Quinidine on Digoxin Kinetics in Cardiac Patients

    Acta Medica Scandinavica

    Volume 207, Issue 1-6, January/December 1980, Pages: 291–295, Knud Erik Pedersen, Jens Hastrup and Steffen Hvidt

    Version of Record online : 24 APR 2009, DOI: 10.1111/j.0954-6820.1980.tb09723.x

  14. You have free access to this content
    Dose-dependent Hemodynamic Effect of Digoxin Therapy in Severe Verapamil Toxicity

    Academic Emergency Medicine

    Volume 11, Issue 3, March 2004, Pages: 221–227, Theodore C. Bania, Jason Chu, Gregory Almond and Eric Perez

    Version of Record online : 8 JAN 2008, DOI: 10.1111/j.1553-2712.2004.tb02201.x

  15. Effects of Pregnancy on CYP3A and P-glycoprotein Activities as Measured by Disposition of Midazolam and Digoxin: A University of Washington Specialized Center of Research Study

    Clinical Pharmacology & Therapeutics

    Volume 84, Issue 2, August 2008, Pages: 248–253, MF Hebert, TR Easterling, B Kirby, DB Carr, ML Buchanan, T Rutherford, KE Thummel, DP Fishbein and JD Unadkat

    Version of Record online : 20 FEB 2008, DOI: 10.1038/clpt.2008.1

  16. You have free access to this content
    The characteristics of the binding of 12-alpha-[3H]-digoxin to the membranes of intact human erythrocytes: relevance to digoxin therapy.

    British Journal of Clinical Pharmacology

    Volume 8, Issue 2, August 1979, Pages: 115–124, AR Ford, JK Aronson, DG Grahame-Smith and JA Rose

    Version of Record online : 4 JUL 2012, DOI: 10.1111/j.1365-2125.1979.tb05809.x

  17. You have free access to this content
    Exposure to sennoside–digoxin interaction and risk of digoxin toxicity: a population-based nested case–control study

    European Journal of Heart Failure

    Volume 13, Issue 11, November 2011, Pages: 1238–1243, Meng-Ting Wang, I-Hsun Li, Wan-Ju Lee, Tien-Yu Huang, Hsin-Bang Leu and Agnes L.F. Chan

    Version of Record online : 18 FEB 2014, DOI: 10.1093/eurjhf/hfr091

  18. Absence of a Clinically Relevant Interaction Between Etanercept and Digoxin

    The Journal of Clinical Pharmacology

    Volume 44, Issue 11, November 2004, Pages: 1244–1251, Dr Honghui Zhou, Ms Virginia Parks, Dr Alain Patat, Dr Franck Le Coz, Ms Donna Simcoe and Dr Joan Korth-Bradley

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270004268050

  19. Changes in Steady State Digoxin Pharmacokinetics during Quinidine Therapy in Cardiac Patients: Influence of Plasma Quinidine Concentration

    Acta Pharmacologica et Toxicologica

    Volume 52, Issue 5, May 1983, Pages: 357–363, Knud Erik Pedersen, Bent Dorff Christiansen, Niels Anders Klitgaard and Folmer Nielsen-Kudsk

    Version of Record online : 13 MAR 2009, DOI: 10.1111/j.1600-0773.1983.tb01115.x

  20. Interpretation of serum digoxin values in renal failure

    Clinical Pharmacology & Therapeutics

    Volume 39, Issue 5, May 1986, Pages: 531–536, Henry Gault, Sudesh Vasdev, Peter Vlasses, Linda Longerich and Madonna Dawe

    Version of Record online : 10 MAY 1986, DOI: 10.1038/clpt.1986.91